Tuesday, August 23, 2011
Mesoblast Ltd., of Melbourne, Australia, reported that the first lumbar disc procedure was successfully performed in the Phase II trial of its adult mesenchymal precursor cell (MPC) product.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.